Articles tagged "Survival"

2015 American Transplant Congress
Survival of Patients With Peripheral Vascular Disease on Kidney Waitlist and After Transplantation: An Analysis of the United State Renal Data System
A. Brar,¹ D. Stefanov,³ R. Jindal,² N. Sumrani,⁴ D. John,⁴ F. Tedla,¹ M. Salifu.¹
¹Department of Medicine, SUNY Downstate Medical Center, Brooklyn, NY; ²Department of Surgery, Walter Reed National Military Medical Center, Uniformed Services University of Health Sciences, Bethesda, MD; ³Division of Research, SUNY Downstate School of Medicine, Brooklyn, NY; ⁴Department of Surgery, SUNY Downstate Medical Center, Brooklyn, NY.
Introduction: There is lack of information whether waitlisted dialysis patients with peripheral vascular disease (PVD) benefit from kidney transplantation.Methods: We used a cohort of USRDS…
2015 American Transplant Congress
Clinical Outcomes of Kidney Transplan Recipients After Sirolimus Or Everolimus Conversion. Experience in a Single Center
L. Mesa, E. Manzi, M. Valderrama, J. Posada, J. Schweineberg, C. Duran, G. Echeverri, J. Villegas, O. Serrano, L. Caicedo.
Transplant Unit, Fundación Valle del Lili, Cali, Colombia.
Introduction. The use of m_TOR inhibitors sirolimus (SRL) and everolimus (EVL), in kidney transplant recipients (KTR) is an alternative immunosuppressive therapy to reduce or withdrawal…
2015 American Transplant Congress
Cancer Mortality Among Recipients of Solid Organ Transplant in Ontario
S. Acuna,^1,2,3 K. Fernandes,⁴ C. Daly,^2,3 L. Hicks,³ R. Sutradhar,^1,4 S. Kim,^1,4 N. Baxter.^1,2,3,4
¹Institute of Health Policy, Management and Education, University of Toronto, Toronto, ON, Canada; ²Department of Surgery, St. Michael's Hospital, Toronto, ON, Canada; ³Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada; ⁴Institute for Clinical Evaluative Sciences, Toronto, ON, Canada.
Purpose: Solid organ transplantation recipients (SOTR) have a higher risk of some cancers than the general population, but are also at high risk of mortality…
2015 American Transplant Congress
Examining Long-Term Survivors in Combined Heart-Lung Transplantation
S. Kadakia,¹ S. Jayarajan,¹ S. Taghavi,¹ V. Ambur,¹ C. Lewis,¹ A. Shiose,² G. Wheatley III,² L. Kaiser,³ T. Guy,² Y. Toyoda.²
¹Department of Surgery, Temple University Hospital, Philadelphia, PA; ²Division of Cardiovascular Surgery, Temple University Hospital, Philadelphia, PA; ³Division of Thoracic Surgery, Temple University Hospital, Philadelphia, PA.
The goal of this study was to determine variables associated with mortality in combined heart-lung transplantation (HLT).The United Network for Organ Sharing (UNOS) database was…
2015 American Transplant Congress
Impact of Elevated BMI on Allograft Outcomes: A Competing Risks Regression Analysis
A. Naik, A. Sakhuja, M. Samaniego, P. Shrivastava, D. Cibrik.
Section of Nephrology, University of Michigan, Ann Arbor, MI.
INTRODUCTION: Extremes of BMI has been associated with an increased risk of death censored allograft failure. Traditionally the KM product limit estimate has been used…
2015 American Transplant Congress
De Novo Once-Daily Tacrolimus in Liver Transplantation: Long-Term Outcomes of a Single Center Cohort of 150 Patients
M. Gastaca, A. Valdivieso, J. Bustamante, P. Ruiz, J. Fernandez, A. Ventoso, M. Testillano, I. Palomares, P. Salvador, M. Prieto, A. Matarranz, M. Suarez, J. Ortiz de Urbina.
Liver Transplantation Unit, Cruces University Hospital. University of the Basque Country, Bilbao, Vizcaya, Spain.
Purpose: To describe the long-term safety and efficacy profile of de novo once-daily tacrolimus (Tac QD) in orthotopic liver transplantation (OLT)Patients and methods: A retrospective…
2015 American Transplant Congress
MELD as a Predictor of Post-Transplant Survival
X. Luo, A. Massie, A. Poon, D. Segev.
Department of Surgery, Johns Hopkins, Baltimore.
MELD is a reliable tool to predict liver waitlist mortality. Previous studies of MELD and post-transplant outcomes have had conflicting results.METHODS: We used generalized gamma…
2015 American Transplant Congress
Survival Benefit of Liver Transplant Among HIV+ Waitlist Candidates
C. Durand,¹ S. Gustafson,² J. Locke,³ J. Snyder,² B. Shelton,³ R. Reed,³ P. MacLennan,³ S. Mehta,³ A. Nellore,³ D. Segev.^1,2
¹Johns Hopkins University, Baltimore, MD; ²Scientific Registry of Transplant Recipients (SRTR), CDRG, Minneapolis, MN; ³University of Alabama, Birmingham, Birmingham, Al.
Liver failure is the most common cause of non-AIDS related death among HIV+ patients, primarily due to high prevalence of co-infection with hepatitis C (HCV)…
2015 American Transplant Congress
Survival Benefit of ECD Transplantation After Ultra-Long Dialysis Exposure: Implications for Acceptance in the New KAS
C. Kennedy, J. Dong, T. Myint, C. Rose, O. Johnston, J. Gill, J. Gill.
Division of Nephrology, University of British Columbia, Vancouver, BC, Canada.
The survival benefit of ECD transplantation varies with the duration of pre-transplant dialysis exposure.We analyzed the survival benefit of ECD transplantation (Kidney Donor Profile Index…
2015 American Transplant Congress
Association of Pulmonary Hypertension at Kidney Transplant Evaluation and Subsequent Outcomes Following Transplantation
Y.-L. Lai,¹ H. Wasse,² W. Kim,³ R. Patzer.^1,4
¹Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA; ²Division of Nephrology/Hypertension, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL; ³Emory University School of Medicine, Atlanta, GA; ⁴Department of Surgery, Emory University School of Medicine, Atlanta, GA.
Background - Pulmonary hypertension (PH) is common among patients with end stage renal disease (ESRD) who depend on dialysis before transplant, and PH is associated…